Taiho Oncology Prepares To Commercialize Products In U.S., Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
The business unit is transitioning from being the clinical development arm of its parent company to a full-blown commercial operation in the U.S. and Europe.